Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark I Furman

Showing results (1-10 of 32) with videos related to

Pageof 4
Sort By:
Coronary Artery Disease|September 4, 2004
The role of platelet inhibition in the drug-eluting stent eraMichael R Tamberella, Mark I Furman
Archives of Internal Medicine|May 30, 2007
Translating evidence into practice: are we neglecting the neediest?John A Spertus, Mark I Furman
Journal of Thrombosis and Thrombolysis|March 4, 2005
GPIIb/IIIa inhibitor-induced dethrombosisMark I Furman, A L Frelinger, Alan D Michelson
The American Journal of Cardiology|November 14, 2006
Current options in platelet function testingAlan D Michelson, Andrew L Frelinger, Mark I Furman
Thrombosis Research|January 24, 2007
Measuring antiplatelet drug effects in the laboratoryPaul Harrison, A L Frelinger, Mark I Furman, et al.
Basic Research in Cardiology|January 20, 2007
'Postconditioning' the human heart: multiple balloon inflations during primary angioplasty may confer cardioprotectionChad E Darling, Patrick B Solari, Craig S Smith, et al.
Current Protocols in Cytometry|September 5, 2008
Whole blood analysis of leukocyte-platelet aggregatesMarc R Barnard, Lori A Krueger, A L Frelinger, et al.
Journal of Thrombosis and Thrombolysis|October 2, 2002
Activated clotting times in the setting of eptifibatide use during percutaneous coronary interventionHarold L Dauerman, Steven A Ball, Robert J Goldberg, et al.
The American Journal of Cardiology|August 14, 2003
Leukocytosis and adverse hospital outcomes after acute myocardial infarctionVandana Menon, Darleen Lessard, Jorge Yarzebski, et al.
Current Protocols in Cytometry|September 5, 2008
Immunophenotypic analysis of plateletsLori A Krueger, Marc R Barnard, A L Frelinger, et al.
Pageof 4

Showing results (1-10 of 32) with videos related to

Sort By:
Pageof 4
Coronary Artery Disease|September 4, 2004
The role of platelet inhibition in the drug-eluting stent eraMichael R Tamberella, Mark I Furman
Archives of Internal Medicine|May 30, 2007
Translating evidence into practice: are we neglecting the neediest?John A Spertus, Mark I Furman
Journal of Thrombosis and Thrombolysis|March 4, 2005
GPIIb/IIIa inhibitor-induced dethrombosisMark I Furman, A L Frelinger, Alan D Michelson
The American Journal of Cardiology|November 14, 2006
Current options in platelet function testingAlan D Michelson, Andrew L Frelinger, Mark I Furman
Thrombosis Research|January 24, 2007
Measuring antiplatelet drug effects in the laboratoryPaul Harrison, A L Frelinger, Mark I Furman, et al.
Basic Research in Cardiology|January 20, 2007
'Postconditioning' the human heart: multiple balloon inflations during primary angioplasty may confer cardioprotectionChad E Darling, Patrick B Solari, Craig S Smith, et al.
Current Protocols in Cytometry|September 5, 2008
Whole blood analysis of leukocyte-platelet aggregatesMarc R Barnard, Lori A Krueger, A L Frelinger, et al.
Journal of Thrombosis and Thrombolysis|October 2, 2002
Activated clotting times in the setting of eptifibatide use during percutaneous coronary interventionHarold L Dauerman, Steven A Ball, Robert J Goldberg, et al.
The American Journal of Cardiology|August 14, 2003
Leukocytosis and adverse hospital outcomes after acute myocardial infarctionVandana Menon, Darleen Lessard, Jorge Yarzebski, et al.
Current Protocols in Cytometry|September 5, 2008
Immunophenotypic analysis of plateletsLori A Krueger, Marc R Barnard, A L Frelinger, et al.
Pageof 4